REGENXBIO to Participate in Upcoming Investor Conferences
REGENXBIO Inc. (Nasdaq: RGNX) has announced its participation in two upcoming investor conferences. The company will be present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, at 5:35 p.m. ET, and the Baird 2024 Global Healthcare Conference on September 11, 2024, at 9:40 a.m. ET. Both events will take place in New York, NY.
Investors can access live webcasts of the fireside chats from both conferences through the Investors section of REGENXBIO's website. Archived replays will be available for approximately 30 days after each presentation. This participation in high-profile healthcare conferences suggests REGENXBIO's commitment to engaging with investors and showcasing its developments in the biotechnology sector.
REGENXBIO Inc. (Nasdaq: RGNX) ha annunciato la sua partecipazione a due conferenze per investitori in programma. L'azienda sarà presente al 22° Annual Global Healthcare Conference di Morgan Stanley il 5 settembre 2024, alle 17:35 ET, e alla Baird 2024 Global Healthcare Conference l'11 settembre 2024, alle 9:40 ET. Entrambi gli eventi si terranno a New York, NY.
Gli investitori potranno accedere alle dirette streaming delle conversazioni informali di entrambe le conferenze attraverso la sezione Investitori del sito web di REGENXBIO. Le registrazioni archiviate saranno disponibili per circa 30 giorni dopo ogni presentazione. Questa partecipazione a conferenze sanitarie di alto profilo suggerisce l'impegno di REGENXBIO nel coinvolgere gli investitori e nel mettere in evidenza i suoi sviluppi nel settore biotecnologico.
REGENXBIO Inc. (Nasdaq: RGNX) ha anunciado su participación en dos conferencias de inversores próximas. La compañía estará presente en la 22ª Conferencia Anual Global de Salud de Morgan Stanley el 5 de septiembre de 2024, a las 5:35 p.m. ET, y en la Conferencia Global de Salud 2024 de Baird el 11 de septiembre de 2024, a las 9:40 a.m. ET. Ambos eventos tendrán lugar en Nueva York, NY.
Los inversores podrán acceder a las transmisiones en vivo de las charlas informales de ambas conferencias a través de la sección de Inversores del sitio web de REGENXBIO. Las repeticiones archivadas estarán disponibles durante aproximadamente 30 días después de cada presentación. Esta participación en conferencias sanitarias de alto perfil sugiere el compromiso de REGENXBIO de involucrar a los inversores y mostrar sus desarrollos en el sector biotecnológico.
REGENXBIO Inc. (Nasdaq: RGNX)는 다가오는 두 개의 투자자 회의에 참가할 것이라고 발표했습니다. 이 회사는 2024년 9월 5일 오후 5시 35분 ET에 열리는 모건 스탠리 제22회 연례 글로벌 헬스케어 회의와 2024년 9월 11일 오전 9시 40분 ET에 열리는 베어드 2024 글로벌 헬스케어 회의에 참석할 예정입니다. 두 이벤트 모두 뉴욕, NY에서 열립니다.
투자자들은 REGENXBIO 웹사이트의 투자자 섹션을 통해 두 회의의 주요 대화의 실시간 웹캐스트에 접근할 수 있습니다. 각 프레젠테이션 후 약 30일 동안 아카이브된 재생이 제공될 예정입니다. 이와 같은 저명한 헬스케어 회의에의 참여는 투자자와 소통하고 생명공학 분야에서의 개발을 선보이려는 REGENXBIO의 의지를 나타냅니다.
REGENXBIO Inc. (Nasdaq: RGNX) a annoncé sa participation à deux conférences pour investisseurs à venir. La société sera présente à la 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley le 5 septembre 2024 à 17h35 ET, et à la Conférence Mondiale sur la Santé 2024 de Baird le 11 septembre 2024 à 9h40 ET. Les deux événements auront lieu à New York, NY.
Les investisseurs pourront accéder aux diffusions en direct des discussions informelles des deux conférences via la section Investisseurs du site web de REGENXBIO. Les rediffusions archivées seront disponibles pendant environ 30 jours après chaque présentation. Cette participation à des conférences de santé de haut niveau suggère l'engagement de REGENXBIO à dialoguer avec les investisseurs et à mettre en avant ses développements dans le secteur biotechnologique.
REGENXBIO Inc. (Nasdaq: RGNX) hat die Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen wird am 5. September 2024 um 17:35 Uhr ET an der 22. jährlichen Global Healthcare Conference von Morgan Stanley und am 11. September 2024 um 9:40 Uhr ET an der Baird 2024 Global Healthcare Conference teilnehmen. Beide Veranstaltungen finden in New York, NY statt.
Investoren können die Live-Webcasts der informellen Gespräche beider Konferenzen über den Investor-Bereich der Website von REGENXBIO verfolgen. Archivierte Aufzeichnungen werden etwa 30 Tage nach jeder Präsentation verfügbar sein. Diese Teilnahme an hochkarätigen Gesundheitskonferenzen deutet auf das Engagement von REGENXBIO hin, mit Investoren in Kontakt zu treten und seine Entwicklungen im Bereich der Biotechnologie zu präsentieren.
- None.
- None.
Morgan Stanley 22nd Annual Global Healthcare Conference
Fireside Chat: Thursday, September 5, 2024 at 5:35 p.m. ET
Location:
Baird 2024 Global Healthcare Conference
Fireside Chat: Wednesday, September 11, 2024 at 9:40 a.m. ET
Location:
Live webcasts of the fireside chats at the Morgan Stanley and Baird conferences can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com. An archived replay of each webcast will be available for approximately 30 days following the presentation.
ABOUT REGENXBIO Inc.
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIO's AAV Therapeutic platform, including Novartis' ZOLGENSMA® for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people. For more information, please visit www.regenxbio.com.
Contacts:
Dana Cormack
Corporate Communications
dcormack@regenxbio.com
Investors:
Chris Brinzey, ICR Westwicke
339-970-2843
chris.brinzey@westwicke.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-302234421.html
SOURCE REGENXBIO Inc.
FAQ
When is REGENXBIO (RGNX) participating in the Morgan Stanley Global Healthcare Conference?
What is the date and time for REGENXBIO's (RGNX) fireside chat at the Baird Global Healthcare Conference?
How can investors access REGENXBIO's (RGNX) conference presentations?
How long will the archived replays of REGENXBIO's (RGNX) conference presentations be available?
